Dr Sara Trompeter is a Consultant Haematologist and Paediatric Haematologist at University College Hospitals London and NHS Blood and Transplant. She graduated from the University of Bristol in 1997 with degrees in Medicine (MBChB) and Psychology (BSc). She was awarded MRCPCH by the Royal College of Paediatrics and Child Health in 1999, FRCPath by the Royal College of Pathologists in 2006 and an MSc in Evidence Based Health Care at the University of Oxford 2017.
The treatments of red cell, thalassaemia and sickle cell disorders have been a long term interest of Dr Trompeter. She is lead of the Paediatric Red Cell Service at UCLH and previous Chair of the Joint Red Cell Unit Haemoglobinopathy Network including hospitals: UCLH, Whittington Health, Royal Free Hospital, Royal Free Hospital (Barnet Branch) and Luton and Dunstable Hospitals and led the trust through the 2012 Peer Review Process. She has supported and developed the growth of the automated exchange service at UCLH to be the largest in Europe. She is the NHS Blood and Transplant Representative on the Clinical Reference Group for Haemoglobinopathies and has been charged with authoring the Transfusion Policy for Sickle Cell Disease for NHS England.
She is involved in various clinical trials in sickle cell and blood alongside colleagues such as Professor Anstee, Professor Porter and Professor Rees. Much of her research interest involves looking at microvesicles and coagulation in sickle cell disease, stem cell generated blood and pathogen inactivated blood as well as novel therapies in haemoglobin disorders. She has lectured and published on many aspects of red cell disorders.
In her role at NHS Blood and Transplant she is developing an evidence base for transfusion in haemoglobinopathies and is involved in various projects including looking at the feasibility of genotyping donors; the haemoglobinopathy patient genotyping project where all patients in England were offered free genotyping including CDE variants and was the lead on the National Comparative Audit of Transfusion in sickle cell disease 2017. She chairs NHS Blood and Transplant’s Haemoglobinopathy Steering Group whose aspirations are to; Identify the current and future transfusion needs of haemoglobinopathy patients; provide NHSBT with the best information available on current gaps in provision and future demand and requirements; develop audits relating to appropriate blood transfusion for the benefit of haemoglobinopathy patients; raise the profile and importance of the transfusion of haemoglobinopathy patients within NHSBT; be informed regarding research developments and secure funding for research and development of transfusion therapy in sickle cell disease and support and liaise with the donor area of NHSBT to inform and encourage donations that may benefit the patient group.
Access to the appropriate level of care for patients with haemoglobin and other red cell disorders has often been a challenge for this patient group. Dr Trompeter is pleased to offer the support and care that this group needs with access to:
- Annual reviews
- Advice regarding medical care needed prior and following and operation in those with red cell disorders
- Prenatal and Antenatal counselling and diagnosis of haemoglobin disorders in carrier parents
- Manual red cell exchange
- Automated red cell exchange (apheresis)
- Hydroxyurea therapy and monitoring
- Chelation e.g. desferrioxamine (desferal); deferasirox (exjade); deferiprone (L1).
- Routine outpatient review for red cell disorders
- Iron therapy
Other specialists where needed e.g. cardiologists and surgeons specialising in sickle cell and thalassaemia
She is available for consultations at Harley Street at UCH and appointments can be made with her secretary on 020 3447 1717 or email@example.com.